Clinical Trial Update: Aflibercept for Retinopathy in the Real World

View source ↗

Summary

A real-world trial evaluating aflibercept for diabetic retinopathy (NCT02812030) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Timothy Jones | Conditions: Diabetic Retinopathy | Status: WITHDRAWN